February 15, 2007

Illuminus is a Duke spinoff company developing technology to measure the removal of breast tumors during breast conserving surgery. An estimated 125,000 women diagnosed with early stage breast cancer receive breast conserving surgery each year. The project manager, Dr. Nimmi Ramanujam, an internationally recognized researcher in biomedical engineering, will provide the technical direction for the venture. She is a tenured faculty member at Duke University. She was the winner of the MIT Technology Review TR100 award in 2003, winner of the U.S. Department of Defense Hope Award in 2004 for outstanding research contributions to the study of breast cancer and winner of the MIT Global Indus Technovators Award in 2005. Her previous research on cervical cancer detection has spawned several startups by third-party licensees. Her team includes Assistant Professor of Surgery, Lee Wilke, Professor of Pathology, Joseph Geradts, Business Strategist, Melda Uzbil, and Senior Associate Dean for Industrial Partnerships and Research Commercialization at Duke, Barry Myers. Contact: Ramanujam